Current Prognostic Biomarkers for Abdominal Aortic Aneurysm: A Comprehensive Scoping Review of the Literature

Hamzah Khan,Mohamed Abu-Raisi,Manon Feasson,Farah Shaikh,Gustavo Saposnik,Muhammad Mamdani,Mohammad Qadura
DOI: https://doi.org/10.3390/biom14060661
IF: 6.064
2024-06-05
Biomolecules
Abstract:Abdominal aortic aneurysm (AAA) is a progressive dilatation of the aorta that can lead to aortic rupture. The pathophysiology of the disease is not well characterized but is known to be caused by the general breakdown of the extracellular matrix within the aortic wall. In this comprehensive literature review, all current research on proteins that have been investigated for their potential prognostic capabilities in patients with AAA was included. A total of 45 proteins were found to be potential prognostic biomarkers for AAA, predicting incidence of AAA, AAA rupture, AAA growth, endoleak, and post-surgical mortality. The 45 proteins fell into the following seven general categories based on their primary function: (1) cardiovascular health, (2) hemostasis, (3) transport proteins, (4) inflammation and immunity, (5) kidney function, (6) cellular structure, (7) and hormones and growth factors. This is the most up-to-date literature review on current prognostic markers for AAA and their functions. This review outlines the wide pathophysiological processes that are implicated in AAA disease progression.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the identification and classification of current plasma/serum protein biomarkers used to predict the progression of abdominal aortic aneurysm (AAA). Specifically, the paper aims to identify these biomarkers through a comprehensive literature review and classify them according to their primary physiological functions, with the goal of better understanding the pathogenesis of AAA and laying the groundwork for further research that could eventually validate and apply these biomarkers in clinical settings. Additionally, the paper hopes to inform future efforts to integrate these biomarkers into machine learning models to improve patient risk stratification. The paper covers research from 2010 to 2023, analyzing a total of 45 potential predictive protein biomarkers, which are categorized into seven main groups: cardiovascular health, coagulation function, transport proteins, inflammation and immunity, renal function, cell structure, and hormones and growth factors.